Skip to main content
. 2018 Nov 21;7(12):1442–1447. doi: 10.1530/EC-18-0438

Table 2.

Adjusted linear regression comparing step count change (1000 steps) with changes in markers of inflammation, T2DM and CVD.

Characteristic Unstandardised beta co-efficient (95% CI) P value
Δ IL6, ng/L −0.81 (−1.37, −0.25) 0.005
Δ CRP, mg/L −0.68 (−1.31, −0.06) 0.033
Δ Fasting insulin, mIU/L 0.61 (−0.68, 1.90) 0.348
Δ HOMA IR 0.17 (−0.02, 0.35) 0.086
Δ Fasting glucose, mmol/L 0.17 (−0.034, 0.068) 0.509
Δ HbA1C, % 0.04 (−0.00, 0.075) 0.056
Δ LDL, mmol/L −0.027 (−0.1, 0.045) 0.455
Δ HDL, mmol/L −0.011 (0.07, 0.09) 0.792
Δ Diastolic BP 0.55 (−0.75, 1.84) 0.402
Δ Systolic BP 0.54 (−1.04, 2.13) 0.497
Δ Body mass index, kg/m2 −0.20 (−0.38, −0.01) 0.038

P values of <0.05 are in italics. Analyses were adjusted for age (at baseline), ethnicity, baseline step count, change in accelerometer wear-time and change in BMI. For analysis of Δ BMI vs Δ step count adjustments for age (at baseline), ethnicity, baseline step count, change in accelerometer wear-time.